Home > Insider Trading > Filing (0001104659-23-127037)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1819576	Liquidia Corp	LQDA	Pharmaceutical Preparations (2834)	851710962

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1935638	Rajeev Saggar	419 Davis Drive, Suite 100 Morrisville NC 27560	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-12-18	14,887	$7.42	164,099	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

On July 18, 2022, the Reporting Person was awarded an aggregate of 93,834 restricted stock units ("RSUs"), all of which, including the unvested portion, were reported on a Form 4 filed on July 20, 2022. The vesting of 52,782 of those previously reported RSUs was deferred until December 14, 2023. As reported on this Form 4, only the requisite amount of shares were sold to cover the required taxes in connection with the vesting and settlement of the 52,782 previously reported RSUs.
Includes (i) 93,384 RSUs granted to the Reporting Person on July 18, 2022, of which 52,782 have vested as of the date of this Form 4, (ii) 83,333 RSUs granted to the Reporting Person on January 11, 2023, none of which have vested as of the date of this Form 4 and (iii) 1,819 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan on August 31, 2023.